Preclinical WebsiteClinical Website

Model Overview

The cuprizone model of demyelination/remyelination is induced by feeding mice the copper-chelating cuprizone toxin. Cuprizone administration models several aspects of human multiple sclerosis (MS), including demyelination, spontaneous remyelination, oligodendrocyte precursor cell (OPC) proliferation & maturation, astrogliosis, and microgliosis. The pathology in the cuprizone model is primarily limited to the corpus callosum with highly predictable pathology.

Unlike EAE, cuprizone is not autoimmune mediated and the demyelination/remyelination is not confounded by a peripheral immune response. EAE and cuprizone model different aspects of MS pathology, and therapeutic studies are often performed in parallel.

Model Generation

  • C57BL/6 mice are fed 0.2-0.3% cuprizone via powdered chow, food pellets, or oral gavage
  • A more severe, chronic model can be generated by injecting rapamycin (i.p. 5 days per week)
  • In our experience, the powdered chow route of administration provides the most reproducible results

Our Validated Measures

  • Body weight
  • Myelin-sensitive in vivo MRI
  • Immunohistochemistry & multiplex immunofluorescence of the corpus callosum

Myelin Basic Protein (MBP) immunohistochemistry staining of the corpus callosum in control mice (top) and mice fed 0.3% cuprizone for 5 weeks (bottom).

Learn more about our characterization of this model and our validated measures.

Discover more of our Multiple Sclerosis Models

FAQs

What are the advantages of in vivo MRI for the cuprizone model?

We use the Magnetization Transfer Ratio (MTR) to assess demyelination and remyelination this model.

two

Key advantages include:

  • Clinically translational measure that is widely used in MS clinical trials
  • Longitudinal assessment in the same animal
  • In-life readout for faster go/no-go decision-making

What is the typical time course of demyelination and remyelination in the cuprizone model?

Here is an illustration of a typical time course:

/


Is inflammation observed in the cuprizone model?

Cuprizone is an excellent model of neuroinflammation (microgliosis and astrogliosis). Here is a typical time course:

/

/

Unlike EAE, it does not show significant peripheral inflammatory infiltrates, such as T cells.


Can cuprizone and EAE studies be performed in parallel?

Yes. Since cuprizone and EAE model different aspects of human MS, they can be run as parallel studies for a comprehensive assessment of therapeutic agents on demyelination, remyelination, neuroinflammation, peripheral inflammation, axonal damage, etc.


What is the cuprizone-rapamycin model?

By adding rapamycin (typically i.p. administration 5 days per week) to the cuprizone model, a more severe model can be generated. The option to include rapamycin in the model generation depends on your therapeutic agent and the questions that you are trying to answer. Our MS model scientists would be happy to discuss the pros and cons of this model with you.


More Information

Let us know what you’re interested in. Our team will be happy to discuss with you!

Email us at i[email protected] or simply complete & submit the form below. 

Name*
Email*
Phone Number*
Affiliation (Company/University)*
Message*

Your privacy is important to us. We will protect your data as outlined in our Privacy Notice.

I agree to the terms in the Privacy Notice*

We use necessary cookies to make our site work. We also use other cookies to help us make improvements by measuring how you use the site or for marketing purposes. You have the choice to accept or reject them all. For more detailed information about the cookies we use, see our Privacy Notice.